Gadolinium retention effect on macrophages - a potential cause of MRI contrast agent Dotarem toxicity

Marta Halasa1,2, Ahmed Uosef1,2, Henry V Ubelaker1,2

  • 1Transplant Immunology, The Houston Methodist Research Institute, 6670 Bertner Ave., Houston, TX, 77030, USA.

PubMed

Insights

Gadolinium from MRI contrast agents accumulates in macrophages, impairing immune cell function. Long-term gadolinium retention significantly reduces macrophage motility and alters key immune and fibrotic pathways, potentially harming patients.

Area of Science:

  • Immunology
  • Toxicology
  • Biomedical Imaging

Background:

  • Gadolinium-based contrast agents (GBCAs) like Dotarem are widely used in MRI.
  • Gadolinium accumulates in organs and tissues, with potential long-term toxic effects.
  • Previous studies show gadolinium retention in macrophages for at least 7 days post-exposure.

Purpose of the Study:

  • To investigate the impact of gadolinium retention on macrophage function and molecular pathways.
  • To assess the effects of 1-day and 7-day gadolinium exposure on macrophage behavior.

Main Methods:

  • Macrophage cultures exposed to gadolinium for 1 and 7 days.
  • Analysis of macrophage adhesion, motility, protein expression, and mRNA transcription.
  • Focus on proteins and genes related to adhesion, fibrosis, and immune response.

Main Results:

  • Seven-day gadolinium retention significantly decreased macrophage adhesion and motility.
  • Dysregulated expression of proteins (Notch1, Jagged1, PAK1, Shp1, Smad3, TCF19) and chemokines (CXCL10, CXCL13).
  • Altered mRNA expression of fibrosis genes (Col6a1, Fibronectin, MMP9, MMP12) and complete suppression of the M2 marker Arg-1.

Conclusions:

  • Gadolinium retention in macrophages disrupts critical cellular functions and molecular pathways.
  • Observed changes may negatively impact the patient's immune system and response.
  • Further research is needed to understand the clinical implications of gadolinium-induced macrophage dysfunction.